125 related articles for article (PubMed ID: 26242718)
1. Lethal leukoencephalopathy secondary to Tegafur, a 5-fluorouracil prodrug.
Sierra S; Luquin N; Carrato C
J Neurol Sci; 2015 Oct; 357(1-2):326-8. PubMed ID: 26242718
[No Abstract] [Full Text] [Related]
2. Capecitabine-induced Leukoencephalopathy.
Yoshimura K; Tokunaga S; Daga H; Inoue M
Intern Med; 2019 Feb; 58(4):621-622. PubMed ID: 30333392
[No Abstract] [Full Text] [Related]
3. Standard-dose tegafur combined with uracil is not safe treatment after severe toxicity from 5-fluorouracil or capecitabine.
Deenen MJ; Terpstra WE; Cats A; Boot H; Schellens JH
Ann Intern Med; 2010 Dec; 153(11):767-8. PubMed ID: 21135311
[No Abstract] [Full Text] [Related]
4. 5-FU induced acute toxic leukoencephalopathy: early recognition and reversibility on DWI-MRI.
Maheen Anwar SS; Mubarak F; Sajjad Z; Azeemuddin M
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S8-10. PubMed ID: 24718016
[TBL] [Abstract][Full Text] [Related]
5. Teaching NeuroImages: 5-FU-induced acute leukoencephalopathy.
Mehta S; Singh G; Paul BS
Neurology; 2013 Apr; 80(18):e191. PubMed ID: 23628936
[No Abstract] [Full Text] [Related]
6. A unique radiological case of intrathecal methotrexate-induced toxic leukoencephalopathy.
Yang J; Kim GS; Park HM
J Neurol Sci; 2015; 353(1-2):169-71. PubMed ID: 25912173
[No Abstract] [Full Text] [Related]
7. Early detection of 5-FU-induced acute leukoencephalopathy on diffusion-weighted MRI.
Akitake R; Miyamoto S; Nakamura F; Horimatsu T; Ezoe Y; Muto M; Chiba T
Jpn J Clin Oncol; 2011 Jan; 41(1):121-4. PubMed ID: 20926409
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-induced toxic leukoencephalopathy: an uncommon stroke mimic.
Maas RPPWM; Pegge SAH; Evers D; van Samkar A; Klijn CJM
Neurol Sci; 2019 Jun; 40(6):1307-1309. PubMed ID: 30637582
[No Abstract] [Full Text] [Related]
9. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
Okuda H; Ogura K; Kato A; Takubo H; Watabe T
J Pharmacol Exp Ther; 1998 Nov; 287(2):791-9. PubMed ID: 9808711
[TBL] [Abstract][Full Text] [Related]
10. [Three cases of corneal disorders associated with an oral anticancer drug S-1].
Ito S; Tanaka A
Nippon Ganka Gakkai Zasshi; 2006 Nov; 110(11):919-23. PubMed ID: 17134039
[TBL] [Abstract][Full Text] [Related]
11. [Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI].
Shimoyama R; Ban T; Miyake K; Isogai N; Ikegaya Y; Kawachi J; Ogino H; Watanabe K
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1251-3. PubMed ID: 25335709
[TBL] [Abstract][Full Text] [Related]
12. Leukoencephalopathy induced by chemotherapy with tegafur, a 5-fluorouracil derivative.
Ohara S; Hayashi R; Hata S; Itoh N; Hanyu N; Yamamoto K
Acta Neuropathol; 1998 Nov; 96(5):527-31. PubMed ID: 9829818
[TBL] [Abstract][Full Text] [Related]
13. Photosensitivity from oral administration of a fluorouracil derivative (FT 207).
Sun CC; Hsu SC
Photodermatol; 1984 Apr; 1(2):94-5. PubMed ID: 6442417
[No Abstract] [Full Text] [Related]
14. [Picture in clinical hematology no. 69--Case of asymptomatic limbic leukoencephalopathy due to methotrexate therapy].
Kida J; Uemura M; Araya T; Matsumoto K; Imataki O; Takahashi T; Kimura N
Rinsho Ketsueki; 2014 Jan; 55(1):1. PubMed ID: 24492028
[No Abstract] [Full Text] [Related]
15. Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug.
Fukushima S; Hatta N
Br J Dermatol; 2004 Sep; 151(3):698-700. PubMed ID: 15377362
[TBL] [Abstract][Full Text] [Related]
16. Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature.
Shakhbazova A; Marsch AF
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045142
[TBL] [Abstract][Full Text] [Related]
17. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma.
Rubiales AS; del Valle ML
Cancer; 1999 Apr; 85(8):1866-7. PubMed ID: 10223583
[No Abstract] [Full Text] [Related]
18. Reversible leukoencephalopathy with stroke-like presentation in a patient with 5-dihydropyrimidine dehydrogenase deficiency treated with continuous 5-fluorouracil infusion.
Li J; Lee JJ; Chu E; Baehring JM
Clin Colorectal Cancer; 2012 Sep; 11(3):215-7. PubMed ID: 22410472
[No Abstract] [Full Text] [Related]
19. 5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer.
Acharya G; Cruz Carreras MT; Rice TW
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29167217
[TBL] [Abstract][Full Text] [Related]
20. [Patient preference for oral chemotherapy].
Schöffski P
Krankenpfl J; 2002; 40(1-2):40-1. PubMed ID: 12035416
[No Abstract] [Full Text] [Related]
[Next] [New Search]
